Analysis of gene expression and Ig transcription in PU.1/Spi-B-deficient progenitor B cell lines

被引:44
作者
Schweitzer, BL [1 ]
DeKoter, RP [1 ]
机构
[1] Univ Cincinnati, Coll Med, Dept Mol Genet, Cincinnati, OH 45267 USA
关键词
D O I
10.4049/jimmunol.172.1.144
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A number of presumptive target genes for the Ets-family transcription factor PU.1 have been identified in the B cell lineage. However, the precise function of PU.1 in B cells has not been studied because targeted null mutation of the PU.1 gene results in a block to lymphomyeloid development at an early developmental stage. In this study, we take advantage of recently developed PU.1(-/-)Spi-B-/- IL-7 and stromal cell-dependent progenitor B (pro-B) cell lines to analyze the function of PU.1 and Spi-B in B cell development. We show that contrary to previously published expectations, PU.1 and/or Spi-B are not required for IgH chain (IgH) gene transcription in pro-B cells. In fact, PU.1(-/-)Spi-B-/- pro-B cells have increased levels of IgH transcription compared with wild-type pro-B cells. In addition, high levels of Igkappa transcription are induced after IL-7 withdrawal of wild-type or PU.1(-/-)Spi-B-/- pro-B cells. In contrast, we found that Iglambda transcription is reduced in PU.1(-/-)Spi-B-/- pro-B cells relative to wild-type pro-B cells after IL-7 withdrawal. These results suggest that Iglambda, but not IgH or Igkappa, transcription, is dependent on PU.1 and/or Spi-B. The PU.1(-/-)Spi-B-/- pro-B cells have other phenotypic changes relative to wild-type pro-B cells including increased proliferation, increased CD25 expression, decreased c-Kit expression, and decreased RAG-I expression. Taken together, our observations suggest that reduction of PU.1 and/or Spi-B activity in pro-B cells promotes their differentiation to a stage intermediate between late pro-B cells and large pre-B cells.
引用
收藏
页码:144 / 154
页数:11
相关论文
共 66 条
[31]   IMPAIRED EXPANSION OF MOUSE B-CELL PROGENITORS LACKING BTK [J].
KERNER, JD ;
APPLEBY, MW ;
MOHR, RN ;
CHIEN, S ;
RAWLINGS, DJ ;
MALISZEWSKI, CR ;
WITTE, ON ;
PERLMUTTER, RM .
IMMUNITY, 1995, 3 (03) :301-312
[32]   Episomal vectors rapidly and stably produce high-titer recombinant retrovirus [J].
Kinsella, TM ;
Nolan, GP .
HUMAN GENE THERAPY, 1996, 7 (12) :1405-1413
[33]   THE MACROPHAGE AND B-CELL SPECIFIC TRANSCRIPTION FACTOR PU.1 IS RELATED TO THE ETS ONCOGENE [J].
KLEMSZ, MJ ;
MCKERCHER, SR ;
CELADA, A ;
VANBEVEREN, C ;
MAKI, RA .
CELL, 1990, 61 (01) :113-124
[34]  
Klemsz MJ, 1996, MOL CELL BIOL, V16, P390
[35]   Apoptosis and its modulation during B lymphopoiesis in mouse bone marrow [J].
Lu, LW ;
Osmond, DG .
IMMUNOLOGICAL REVIEWS, 2000, 175 :158-174
[36]  
MA ELG, 2001, J BIOL CHEM, V276, P48000
[37]   A SAFE PACKAGING LINE FOR GENE-TRANSFER - SEPARATING VIRAL GENES ON 2 DIFFERENT PLASMIDS [J].
MARKOWITZ, D ;
GOFF, S ;
BANK, A .
JOURNAL OF VIROLOGY, 1988, 62 (04) :1120-1124
[38]   Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities [J].
McKercher, SR ;
Torbett, BE ;
Anderson, KL ;
Henkel, GW ;
Vestal, DJ ;
Baribault, H ;
Klemsz, M ;
Feeney, AJ ;
Wu, GE ;
Paige, CJ ;
Maki, RA .
EMBO JOURNAL, 1996, 15 (20) :5647-5658
[39]  
Melamed D, 1997, J IMMUNOL, V159, P1233
[40]   Synergistic activation of the human Btk promoter by transcription factors Sp1/3 and PU.1 [J].
Müller, S ;
Maas, A ;
Islam, TC ;
Sideras, P ;
Suske, G ;
Philipsen, S ;
Xanthopoulos, KG ;
Hendriks, RW ;
Smith, CIE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 259 (02) :364-369